Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company

  • Optimised vendor-associated costs across geographies

  • Identified billing arrangements across law firms

  • A global top 10 pharmaceutical company wanted to benchmark legal billing rates to the industry average, to reduce legal costs through better negotiation
  • Key challenges were :
    • The different billing arrangements across law firms and geographies
    • The different charge rates based on practice area, firm size, city and experience
  • Competitive analysis :
    • Examined arrangements offered by law firms and identified the preferred billing rate model
    • Assessed average billing rates for job roles (partners, associates and paralegals) in each geography (the US, Canada, UK and Australia)
    • Assessed average billing rates by practice area, industry, firm size, city and experience, and in the healthcare sector
  • Industry demand and supply :
    • Studied impact of demand and supply on legal billing rates
  • Key shifts :
    • Assessed key shifts in billing rate models
    • Assessed key shifts in demand areas
    • Assessed key shifts in supply industry
  • Identified hourly billing asthe most commonly adopted billing arrangement
  • Helped the procurement team reduce the company’s legal costs by negotiating billing rates, while increasing the quality of legal services
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Identified opportunities for expansion and plausible revenue streams

Identified potential geographies and activation levers from competitors

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Product launch strategy for European biopharmaceutical company
What we are proud of

Identified geographical concentration of demand

Designed optimal distribution channel configuration

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration

Patient treatment pathway analysis for venom allergies
What we are proud of

Increased customer/patient satisfaction and conversion rate

Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway